0 135

Cited 0 times in

Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress

Authors
 Do-Youn Oh  ;  Jin Won Kim  ;  Myung Ah Lee  ;  Ilhwan Kim  ;  Choong-kun Lee  ;  Young Mi Seol  ;  Changhoon Yoo  ;  Sang Cheul Oh  ;  Woo Kyun Bae  ;  Hongjae Chon  ;  In Sil Choi  ;  Jeesun Yoon  ;  Joon Oh Park 
Citation
 JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS621, 2022-02 
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0732-183X 
Issue Date
2022-02
Full Text
https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS621
DOI
10.1200/JCO.2022.40.4_suppl.TPS621
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Choong-kun(이충근) ORCID logo https://orcid.org/0000-0001-5151-5096
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194694
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links